Chronic Obstructive Pulmonary Disease

  • Advair 2016 report

    Advair 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Anoro 2016 report

    Anoro 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Breo 2016 report

    Breo 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Brovana 2016 report

    Brovana 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Daliresp 2016 report

    Daliresp 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Incruse 2016 report

    Incruse 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Perforomist 2016 report

    Perforomist 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Spiriva 2016 report

    Spiriva 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Stiolto 2016 report

    Stiolto 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Symbicort 2016 report

    Symbicort 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Advair Diskus 2015 report

    Advair Diskus 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by...

  • Anoro Ellipta 2015 report

    Anoro Ellipta 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 23 Pages The 5 Key Questions Addressed by...